An open-Label, multicenter, expanded access study of Everolimus in Patients with advanced Nerouendocrine tumors.
عنوان الدراسة
An open-Label, multicenter, expanded access study of Everolimus in Patients with advanced Nerouendocrine tumors.
داعم الدراسة
Novartis
دواء الدراسة
Everolimus
رقم بروتوكول الدراسة
CRAD001K24133
حالة الدراسة
Completed
موقع الدراسة
King Faisal Specialist Hospital and Research Center (Riyadh)
مرحلة الدراسة
3b
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.